| Ansøgningsnr. og dato | 15733497.0 (espacenet) (Federated) (European Patent Register), 20150625 | | Patent/reg.nr. og dato | DK/EP 3160978, 20200729 | | Tilgængelighedsdato | 20170503 | | Prioritetsnr. og dato | IN 2050MU2014, 20140625, GB 201411253, 20140625 | | EP publ. nr. og dato |
EP 3160978 20170503 | | Løbedag | | | Ansøger/indehaver | NuCana plc, 3 Lochside Way
Edinburgh EH12 9DT, GB | | Ansøgers ref. nr. | V2007-090-DK | | Opfinder | GRIFFITH, Hugh, NuCana BioMed Limited
10 Lochside Place
Edinburgh
Scotland EH12 9RG, GB,
MCGUIGAN, Christopher, School of Pharmacy and Pharmaceutical Sciences
Cardiff University
Redwood Building
King Edward VII Avenue
Cardiff
South Glamorgan CF10 3NB, GB,
SLUSARCZYK, Magdalena, School of Pharmacy and Pharmaceutical Sciences
Cardiff University
Redwood Building
King Edward VII Avenue
Cardiff
South Glamorgan CF10 3NB, GB,
SERPI, Michaela, School of Pharmacy and Pharmaceutical Sciences
Cardiff University
Redwood Building
King Edward VII Avenue
Cardiff
South Glamorgan CF10 3NB, GB,
FERRARI, Valentina, 83 West Cliff Road
Ramsgate CT11 9NS, GB | | Fuldmægtig | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/7068 (2006.01) , A61P 35/00 (2006.01) , C07H 19/10 (2006.01) | | Titel/benævnelse | GEMCITABIN-PRODRUGS | | Internationalt ansøgningsnr. | GB2015051857 | | Internationalt publ. nr. | WO2015198058 | | Relateret sag (certifikat) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
